Evidence map›Paper›PMID 20975933›Full record

ArticlePLoS genetics2010

Pervasive cryptic epistasis in molecular evolution.

Mark Lunzer, G Brian Golding, Antony M Dean

Erratum issuedAbstract read
In one paragraph

Article in PLoS genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Emergent time scales of epistasis in protein evolution.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Higher-order epistasis within Pol II trigger loop haplotypes.bioRxiv : the preprint server for biology · 2024
    Article
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Mark LunzerBioTechnology Institute, University of Minnesota, St. Paul, Minnesota, USA.
G Brian Golding
Antony M Dean

Funding

Evolution of a Dehydrogenase in its Adaptive LandscapeR01GM060611 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI DEAN, ANTONY M. · 2001 to 2009
$2.4M
NIGMS NIH HHS GM060611NIGMS NIH HHS R01 GM060611
6 · The paper itself

Abstract

The functional effects of most amino acid replacements accumulated during molecular evolution are unknown, because most are not observed naturally and the possible combinations are too numerous. We created 168 single mutations in wild-type Escherichia coli isopropymalate dehydrogenase (IMDH) that match the differences found in wild-type Pseudomonas aeruginosa IMDH. 104 mutant enzymes performed similarly to E. coli wild-type IMDH, one was functionally enhanced, and 63 were functionally compromised. The transition from E. coli IMDH, or an ancestral form, to the functional wild-type P. aeruginosa IMDH requires extensive epistasis to ameliorate the combined effects of the deleterious mutations. This result stands in marked contrast with a basic assumption of molecular phylogenetics, that sites in sequences evolve independently of each other. Residues that affect function are scattered haphazardly throughout the IMDH structure. We screened for compensatory mutations at three sites, all of which lie near the active site and all of which are among the least active mutants. No compensatory mutations were found at two sites indicating that a single site may engage in compound epistatic interactions. One complete and three partial compensatory mutations of the third site are remote and lie in a different domain. This demonstrates that epistatic interactions can occur between distant (>20Å) sites. Phylogenetic analysis shows that incompatible mutations were fixed in different lineages.

Indexed as

Evolution, MolecularMutation3-Isopropylmalate DehydrogenaseAmino Acid SequenceAmino Acid SubstitutionBacterial ProteinsBase SequenceBinding SitesEpistasis, GeneticEscherichia coliEscherichia coli ProteinsKineticsModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedNAD3-Isopropylmalate DehydrogenaseBacterial ProteinsEscherichia coli ProteinsNAD

Identifiers

PMID20975933
PMCPMC2958800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.